Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Colloquium Supported by Eisai Europe Ltd.: Optimising outcomes of patients with advanced renal cancer

Presentation of two clinical vignettes: Optimising dose-intensity and tolerance

Date

11 Sep 2022

Session

ESMO Colloquium Supported by Eisai Europe Ltd.: Optimising outcomes of patients with advanced renal cancer

Topics

Tumour Site

Renal Cell Cancer

Presenters

Cristina Suarez Rodriguez

Authors

C. Suarez Rodriguez

Author affiliations

  • Oncology Dept., Vall d'Hebron University Hospital, 8035 - Barcelona/ES
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.